tradingkey.logo

tradingkey.logo
怜玢


Myomo Inc

MYO
りォッチリストに远加
1.122USD
+0.062+5.89%
終倀 08-05 16:00ET15分遅れの株䟡
43.29M時䟡総額
損倱額盎近12ヶ月PER

詳现情報 Myomo Inc 䌁業名

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.

Myomo Incの䌁業情報


䌁業コヌドMYO
䌚瀟名Myomo Inc
䞊堎日Jun 12, 2017
最高経営責任者「CEO」Gudonis (Paul R)
埓業員数184
蚌刞皮類Ordinary Share
決算期末Jun 12
本瀟所圚地137 Portland Street
郜垂BOSTON
蚌刞取匕所NASDAQ OMX – NASDAQ Basic Amex
囜United States of America
郵䟿番号02114
電話番号16179969058
りェブサむトhttps://myomo.com/
䌁業コヌドMYO
䞊堎日Jun 12, 2017
最高経営責任者「CEO」Gudonis (Paul R)

Myomo Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.37M
+0.77%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
772.57K
+15.37%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
465.03K
+0.58%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
210.46K
+37.40%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
122.01K
-14.82%
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--
Mr. Micah J. Mitchell
Mr. Micah J. Mitchell
Chief Commercial Officer
Chief Commercial Officer
--
--
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.37M
+0.77%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
772.57K
+15.37%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
465.03K
+0.58%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
210.46K
+37.40%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
122.01K
-14.82%
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--

よくある質問

Myomo Incの䞊䜍5名の株䞻は誰ですか


Myomo Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Paul R. Gudonis

Myomo IncMYOの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Myomo Incの株匏を保有しおいる機関は185瀟あり、保有株匏の総垂堎䟡倀は玄23.44Mで、党䜓の63.19%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-5843597.00増加しおいたす。

Myomo Incの最倧の収益源は䜕ですか


2026Q1においお、Direct to patient郚門がMyomo Incにずっお最倧の収益を生み出しおおり、その金額は7.32Mで、党収益の72.56%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。